Cost-effective virus purification
This mixed-mode resin uses size exclusion and binding to purify viruses for vaccines.
Next-generation vaccines
The future is bright for new technologies to complement traditional options for vaccines. Nucleic acid-based vaccines — delivered by viral vectors, lipid nanoparticles (LNPs), or other means — have made their way to patients with many more in development.
Viral vector vaccines
Viral vector-based vaccines have evolved to join more traditional options. These vaccines can be developed and industrialized rapidly, with platform technology that ensures scalable production ― from cell line development through sterile filtration and filling.
Traditional vaccines
Other vaccine types include recombinant virus vaccines, recombinant vaccines, bacterial toxoid protein vaccines, and live attenuated vaccines. We also support these types of vaccines with technology, tools, and services.
-
Molecules
- mRNA
- Plasmid DNA
- Viral vectors